Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function

DR Raleigh, DM Boe, D Yu, CR Weber… - Journal of Cell …, 2011 - rupress.org
DR Raleigh, DM Boe, D Yu, CR Weber, AM Marchiando, EM Bradford, Y Wang, L Wu…
Journal of Cell Biology, 2011rupress.org
Although the C-terminal cytoplasmic tail of the tight junction protein occludin is heavily
phosphorylated, the functional impact of most individual sites is undefined. Here, we show
that inhibition of CK2-mediated occludin S408 phosphorylation elevates transepithelial
resistance by reducing paracellular cation flux. This regulation requires occludin, claudin-1,
claudin-2, and ZO-1. S408 dephosphorylation reduces occludin exchange, but increases
exchange of ZO-1, claudin-1, and claudin-2, thereby causing the mobile fractions of these …
Although the C-terminal cytoplasmic tail of the tight junction protein occludin is heavily phosphorylated, the functional impact of most individual sites is undefined. Here, we show that inhibition of CK2-mediated occludin S408 phosphorylation elevates transepithelial resistance by reducing paracellular cation flux. This regulation requires occludin, claudin-1, claudin-2, and ZO-1. S408 dephosphorylation reduces occludin exchange, but increases exchange of ZO-1, claudin-1, and claudin-2, thereby causing the mobile fractions of these proteins to converge. Claudin-4 exchange is not affected. ZO-1 domains that mediate interactions with occludin and claudins are required for increases in claudin-2 exchange, suggesting assembly of a phosphorylation-sensitive protein complex. Consistent with this, binding of claudin-1 and claudin-2, but not claudin-4, to S408A occludin tail is increased relative to S408D. Finally, CK2 inhibition reversed IL-13–induced, claudin-2–dependent barrier loss. Thus, occludin S408 dephosphorylation regulates paracellular permeability by remodeling tight junction protein dynamic behavior and intermolecular interactions between occludin, ZO-1, and select claudins, and may have therapeutic potential in inflammation-associated barrier dysfunction.
rupress.org